While the IUIS 2022 classification report (6) states that allergy or atopy is characteristic for these conditions, it does not do so for ARPC1B, PLCG2, and IL6ST deficiencies – all of which had a high prevalence of allergy in our study. This evidence concerns the gene ARPC1B and Allergy.